Patents by Inventor Max Bielohuby

Max Bielohuby has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Use of IGFBP-2 in Senescence Diseases and for the Maintenance of Organ Functions
    Publication number: 20100028302
    Abstract: The present invention relates to the use of an IGFBP-2 (insulin-like growth factor binding protein-2) molecule for the production of a pharmaceutical composition for the regulation of senescence processes in cells, tissues and/or organs for the maintenance and control of tissue and/or organ functions and/or for the treatment or alleviation of senescence symptoms or early senescence, wherein the IGFBP-2 molecule is selected from the group of an IGFBP-2 polypeptide or of a functional fragment thereof and of a nucleic acid encoding an IGFBP-2 polypeptide or a functional fragment or derivative thereof. Moreover, corresponding methods of treatment are provided. The use of IGFBP-2 in the preparation of a pharmaceutical composition in the medical intervention of cachexia is described.
    Type: Application
    Filed: September 26, 2005
    Publication date: February 4, 2010
    Applicant: LUDWIG-MAXIMILIANS- UNIVERSITÄT MÜNCHEN
    Inventors: Andreas Hõflich, Eckhard Wolf, Ingrid Renner-Müller, Petra Renner, Daniela Diehl, Max Bielohuby, Esther Hessel